SARAFEM Reviews (FLUOXETINE HYDROCHLORIDE)

Average Rating: 4.0 (1 Ratings)

Filter Results

Compare SARAFEM with similar:
 ANTIDEPRESSANTS

 Type: Rx Drug

  

SARAFEM  (FLUOXETINE HYDROCHLORIDE):  Fluoxetine is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Fluoxetine may lessen premenstrual symptoms such as irritability, increased appetite, and depression. It may decrease binging and purging behaviors in bulimia.   FDA Approval Date: 2006-05-19 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR SARAFEMCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 4  Depression None Worked wonders F 44 1 years
20mg
5/21/2015
  

SARAFEM  (FLUOXETINE HYDROCHLORIDE):  Fluoxetine is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Fluoxetine may lessen premenstrual symptoms such as irritability, increased appetite, and depression. It may decrease binging and purging behaviors in bulimia.   FDA Approval Date: 2006-05-19 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP